- Email: [email protected]
Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization Provides Survival Benefit for Patients With Unresectable Hepatocellular Carcinoma
338
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
55.4. Does NSQIP Accurately Model Complex Technical Operations Like Major Pancreatic Procedures? R. Shah I. Rubinfeld; Henry Ford Hospital, Detroit, Michigan
55.5. Routine Closed Suction Drainage Of Pancreatic Resection In The Setting Of A Soft Pancreas: Is It Necessary? S. Aboudi, J. A. Waters, J. R. Aguilar-Saavedra, C. M. Schmidt; Indiana University Department of Surgery, Indianapolis, IN
55.6. Recurrent Hepatic Colorectal Metastases: Does The Extent Of Surgical Intervention Impact Outcome? K. A. Zavala, C. S. Cho, R. J. Rettammel, E. R. Winslow, S. M. Weber; University of Wisconsin, Madison, WI
55.7. Prolonged Survival In Patients With Macroscopically Complete Resection Of Pancreatic Neuroendocrine Tumor. I. Deshaies, S. Kavuturu, E. T. Kimchi, J. T. Kaifi, B. D. Saunders, K. F. Staveley-O’Carroll, N. J. Gusani; Section of Surgical Oncology, Penn State College of Medicine, Hershey, PA
55.8. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization Provides Survival Benefit for Patients With Unresectable Hepatocellular Carcinoma. C. L. Marshall, S. T. Orcutt, C. N. Robinson, C. J. Balentine, C. Bechara, P. Kougias, S. S. Awad, P. H. Lin, D. Albo; Baylor College of Medicine, Houston, TX
R. A. Anders,2 T. M. Pawlik1; 1Johns Hopkins University School of Medicine - Department of Surgery, Baltimore, Maryland; 2Johns Hopkins University School of Medicine Department of Pathology, Baltimore, Maryland
55.13. Impact Of Histopathological Response To Neoadjuvant Therapy On Survival And Disease Free Survival In Patients With Esophageal Adenocarcinoma. A. Juhasz,1 A. Sundaram,1 M. Hoshino,1 T. H. Lee,1 C. Deng,2 X. Fang,3 S. K. Mittal1; 1Department of Surgery, Creighton University Medical Center, Omaha, Nebraska; 2 Department of Pathology, Creighton University Medical Center, Omaha, Nebraska; 3Office of Research and Complience, Creighton University, Omaha, Nebraska
55.14. The Impact Of Health Insurance Coverage On Outcomes For U.S. Gastric Cancer Patients. J. K. Smith, S. Ng, J. S. Hill, T. P. McDade, S. A. Shah, J. F. Tseng; Surgical Outcomes Analysis & Research (SOAR), University of Massachusetts Medical School, Worcester, MA
55.15. Risk Factors for Peritoneal Metastasis in Gastric Cancer Patients, and Outcomes Following Surgical Resection in this High-Risk Group. K. R. Parikh, O. S. Chow, G. Jibara, D. M. Labow, S. P. Hiotis; Mount Sinai School of Medicine, Department of Surgery, New York, New York
55.9. Volumetric And Morphological Analysis Of Intraductal Papillary Mucinous Neoplasm Of The Pancreas (IPMN) By Using Computed Tomography (CT) And Magnetic Resonance Imaging (MRI). S. Murayama; Department of Gastroenterological and General Surgery, Faculty of Medicine, Yamagata University, Yamagata, Yamagata
55.16. Major Perioperative Morbidity Does Not Affect Long-Term Survival In Patients Undergoing Esophago-Gastrectomy For Cancer Of The Esophagus Or Gastro-Esophageal Junction. B. Xia, K. A. Chojnacki, E. L. Rosato, B. Weksler, F. E. Rosato, A. C. Berger; Thomas Jefferson University, Philadelphia, PA
55.10. Implementation Of A Perioperative Surgical Care Bundle Reduces Wound Infections In Patients Undergoing Pancreaticoduodenectomy. H. Lavu, M. J. Klinge, L. J. Nowcid, H. E. Cohn, D. R. Grenda, P. K. Sauter, B. E. Leiby, S. P. Croker, E. P. Kennedy, C. J. Yeo; Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA
55.17. Invasive Procedures In Stage IV Cancer Patients. A. Kwok,1,3 Y. Hu,1 W. Jiang,1 G. Ting,2 N. Taback,2 J. Weeks,2,3 C. Greenberg1,2; 1Center for Surgery and Public Health, Department of Surgery, Brigham and Women’s Hospital, Boston, MA; 2Dana-Farber Cancer Institute, Boston, MA; 3Harvard School of Public Health, Boston, MA
55.11. Reoperative Completion Pancreatectomy For Malignant Disease Of The Pancreas: A Report Of 10 Cases. H. Lavu, L. J. Nowcid, M. J. Klinge, K. Mahendraraj, E. L. Rosato, D. R. Grenda, P. K. Sauter, E. P. Kennedy, C. J. Yeo; Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA
55.18. Are Primary And Metastatic Tumors The Same? E. B. Lindholm, C. Anthony, J. Boudreaux, A. Gandolfi, P. Ryan, Y. Wang, E. A. Woltering; Louisiana State University Health Sciences Center, Department of Surgery, New Orleans, Lousiana
55.12. The Role Of Liver Directed Surgery In Patients With Hepatic Metastasis From A Gynecologic Primary Carcinoma: A Comprehensive Single-Institution Study of 87 Patients. S. I. Kamel,1 M. C. De Jong,1 M. A. Choti,1 K. Hirose,1 C. L. Wolfgang,1 B. H. Edil,1 R. D. Schulick,1
55.19. Simultaneous Resection Of Colorectal Primary Tumor And Liver Metastases: Is It Safe? G. N. Contro, W. H. Tseng, R. J. Bold, S. R. Martinez, R. J. Canter, S. L. Chen, V. P. Khatri; UC Davis Medical Center, Department of Surgery, Sacramento, CA
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
55.4. Does NSQIP Accurately Model Complex Technical Operations Like Major Pancreatic Procedures? R. Shah I. Rubinfeld; Henry Ford Hospital, Detroit, Michigan
55.5. Routine Closed Suction Drainage Of Pancreatic Resection In The Setting Of A Soft Pancreas: Is It Necessary? S. Aboudi, J. A. Waters, J. R. Aguilar-Saavedra, C. M. Schmidt; Indiana University Department of Surgery, Indianapolis, IN
55.6. Recurrent Hepatic Colorectal Metastases: Does The Extent Of Surgical Intervention Impact Outcome? K. A. Zavala, C. S. Cho, R. J. Rettammel, E. R. Winslow, S. M. Weber; University of Wisconsin, Madison, WI
55.7. Prolonged Survival In Patients With Macroscopically Complete Resection Of Pancreatic Neuroendocrine Tumor. I. Deshaies, S. Kavuturu, E. T. Kimchi, J. T. Kaifi, B. D. Saunders, K. F. Staveley-O’Carroll, N. J. Gusani; Section of Surgical Oncology, Penn State College of Medicine, Hershey, PA
55.8. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization Provides Survival Benefit for Patients With Unresectable Hepatocellular Carcinoma. C. L. Marshall, S. T. Orcutt, C. N. Robinson, C. J. Balentine, C. Bechara, P. Kougias, S. S. Awad, P. H. Lin, D. Albo; Baylor College of Medicine, Houston, TX
R. A. Anders,2 T. M. Pawlik1; 1Johns Hopkins University School of Medicine - Department of Surgery, Baltimore, Maryland; 2Johns Hopkins University School of Medicine Department of Pathology, Baltimore, Maryland
55.13. Impact Of Histopathological Response To Neoadjuvant Therapy On Survival And Disease Free Survival In Patients With Esophageal Adenocarcinoma. A. Juhasz,1 A. Sundaram,1 M. Hoshino,1 T. H. Lee,1 C. Deng,2 X. Fang,3 S. K. Mittal1; 1Department of Surgery, Creighton University Medical Center, Omaha, Nebraska; 2 Department of Pathology, Creighton University Medical Center, Omaha, Nebraska; 3Office of Research and Complience, Creighton University, Omaha, Nebraska
55.14. The Impact Of Health Insurance Coverage On Outcomes For U.S. Gastric Cancer Patients. J. K. Smith, S. Ng, J. S. Hill, T. P. McDade, S. A. Shah, J. F. Tseng; Surgical Outcomes Analysis & Research (SOAR), University of Massachusetts Medical School, Worcester, MA
55.15. Risk Factors for Peritoneal Metastasis in Gastric Cancer Patients, and Outcomes Following Surgical Resection in this High-Risk Group. K. R. Parikh, O. S. Chow, G. Jibara, D. M. Labow, S. P. Hiotis; Mount Sinai School of Medicine, Department of Surgery, New York, New York
55.9. Volumetric And Morphological Analysis Of Intraductal Papillary Mucinous Neoplasm Of The Pancreas (IPMN) By Using Computed Tomography (CT) And Magnetic Resonance Imaging (MRI). S. Murayama; Department of Gastroenterological and General Surgery, Faculty of Medicine, Yamagata University, Yamagata, Yamagata
55.16. Major Perioperative Morbidity Does Not Affect Long-Term Survival In Patients Undergoing Esophago-Gastrectomy For Cancer Of The Esophagus Or Gastro-Esophageal Junction. B. Xia, K. A. Chojnacki, E. L. Rosato, B. Weksler, F. E. Rosato, A. C. Berger; Thomas Jefferson University, Philadelphia, PA
55.10. Implementation Of A Perioperative Surgical Care Bundle Reduces Wound Infections In Patients Undergoing Pancreaticoduodenectomy. H. Lavu, M. J. Klinge, L. J. Nowcid, H. E. Cohn, D. R. Grenda, P. K. Sauter, B. E. Leiby, S. P. Croker, E. P. Kennedy, C. J. Yeo; Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA
55.17. Invasive Procedures In Stage IV Cancer Patients. A. Kwok,1,3 Y. Hu,1 W. Jiang,1 G. Ting,2 N. Taback,2 J. Weeks,2,3 C. Greenberg1,2; 1Center for Surgery and Public Health, Department of Surgery, Brigham and Women’s Hospital, Boston, MA; 2Dana-Farber Cancer Institute, Boston, MA; 3Harvard School of Public Health, Boston, MA
55.11. Reoperative Completion Pancreatectomy For Malignant Disease Of The Pancreas: A Report Of 10 Cases. H. Lavu, L. J. Nowcid, M. J. Klinge, K. Mahendraraj, E. L. Rosato, D. R. Grenda, P. K. Sauter, E. P. Kennedy, C. J. Yeo; Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA
55.18. Are Primary And Metastatic Tumors The Same? E. B. Lindholm, C. Anthony, J. Boudreaux, A. Gandolfi, P. Ryan, Y. Wang, E. A. Woltering; Louisiana State University Health Sciences Center, Department of Surgery, New Orleans, Lousiana
55.12. The Role Of Liver Directed Surgery In Patients With Hepatic Metastasis From A Gynecologic Primary Carcinoma: A Comprehensive Single-Institution Study of 87 Patients. S. I. Kamel,1 M. C. De Jong,1 M. A. Choti,1 K. Hirose,1 C. L. Wolfgang,1 B. H. Edil,1 R. D. Schulick,1
55.19. Simultaneous Resection Of Colorectal Primary Tumor And Liver Metastases: Is It Safe? G. N. Contro, W. H. Tseng, R. J. Bold, S. R. Martinez, R. J. Canter, S. L. Chen, V. P. Khatri; UC Davis Medical Center, Department of Surgery, Sacramento, CA